Análisis del estado SARS-COV-2COVID-19 en el Ecuador

Abstract

Abstract: In November 2019, a new type of coronavirus was discovered in China called COVID-19, which due to the ease of contagion quickly spread throughout the world. The main problem was the lack of knowledge to treat those infected, where with the latest studies biological indicators appear to prevent morbidity, which also serve for the development of vaccines.In this context, the present research arises that aims to analyze different studies that were developed around the biological components that are intended for prevention and immunization. For this, a descriptive study was proposed with a qualitative approach through a bibliographic analysis.The results show that the biological indicators vary according to the evolution of the virus, which allows identifying what the patient is in, thus the marker is identified, later the Von Willebrand, while in the last phase the D-Dimer, T cells is identified, macrophages, and hypersecretion of pro-inflammatory cytokines. With regard to vaccines, they focus on combating the Covid protein S and are made based on RNA, they differ in their content, since they go through different purification processes and are combined with nanoparticles.